Despite the dedication of mental health professionals, some of our foremost treatments for conditions like bipolar disorder have not changed in decades – not because they are perfect, but because we have not found better alternatives.
Currently, this lack of treatment options leaves, for instance, full remission rates for psychosis at just 25%, and for depression, just 3 out of 10. In other words: if diagnosed with depression, you may have only a 30% chance of each treatment regime being effective.
We find this unacceptable.
That’s why we are on a mission to discover new possibilities for potential treatments, by weaving together:
- Stem cells models to repurpose drugs
- Population data
- Key biological pathways for disease development
- Preclinical models
- Untapped potential of existing medications
- Clinical trials – that vital process for both testing and generating leads